Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Prognosis of Lower Risk Patients with Myelodysplastic Syndromes without Isolated Del(5q) after Failure of Erythropoiesis-Stimulating Agents. a Multicenter Study By the Hellenic MDS Study Group

Athanasios G. Galanopoulos, MD PhD, Christos K. Kontos, PhD, Argiris Symeonidis, MD PhD, Ioannis Kotsianidis, MD PhD, Alexandra Kourakli, MD, Vassiliki Pappa, MD, Thomas Tsiambalis, Anastasia Pouli, MDPhD, Panayiotis Panayiotidis, MD PhD, Paraskevi Roussou, Stamatis Karakatsanis, Kalliopi Zafeiropoulou, Maria Dimou, Theodoros P. Vassilakopoulos, MD PhD, Anna Vardi, MD PhD, Dimitrios Tsokanas, George Drakos, Eleftheria Hatzimichael, Aikaterini Megalakaki, Panagiotis Repousis, MD, Maria Kotsopoulou, Elena E. Solomou, MD PhD, Georgia Kaiafa, Menelaos Konstantinos Papoutselis, Anastasia Sioni, Nikolaos Charchalakis, PhD, Eleni Bouronikou, George Vassilopoulos, MD PhD, Vasileios Lazaris, Athanasios Galanopoulos, MD PhD, Panagiotis Theodorou Diamantopoulos, MD PhD, Flora Kontopidou, Zoi Topouzoglou, Stamatina Kalyva, Helen A. Papadaki, MD PhD, Apostolos Hatzitolios, Achilles Anagnostopoulos, Nikolaos Anagnostopoulos, Nora-Athina Viniou

Blood (2017) 130 (Supplement 1): 2979.

https://doi.org/10.1182/blood.V130.Suppl_1.2979.2979

Published: 2017

Journal Articles

CD4+ T Cells in High-Risk MDS Patients Bear an Aberrant STAT Signaling Biosignature

Eleftheria Lamprianidou, Constantinos Tsatalas, Paraskevi Miltiades, Theodoros P. Vassilakopoulos, Sotirios G Papageorgiou, MD, Athanasios G. Galanopoulos, Sofia Vakalopoulou, MD Ass.Prof.Hematology, Vassilia Garypidou, Evangelia Nakou, Emmanuil Spanoudakis, Ioannis Kotsianidis

Blood (2014) 124 (21): 1906.

https://doi.org/10.1182/blood.V124.21.1906.1906

Published: 2014

Journal Articles

Decrease in Transfusion Needs in Patients with Higher-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia Treated with 5-Azacytidine. a Retrospective Study

Panagiotis Theodorou Diamantopoulos, Konstantinos Zervakis, MD, Athanasios G. Galanopoulos, Panagiotis Bakarakos, Vasiliki Papadopoulou, Theodoros Iliakis, Fani Kalala, Nefeli Giannakopoulou, Niki Rougala, Eleni Variami, Aglaia Dimitrakopoulou, Nora-Athina Viniou

Blood (2014) 124 (21): 5608.

https://doi.org/10.1182/blood.V124.21.5608.5608

Published: 2014

Journal Articles

Expression Of CD25 Antigen On CD34+ Cells Is An Independent Predictor Of Survival In Late Stage MDS Patients Treated With Azacitidine

Ioannis Kotsianidis, Paraskevi Miltiades, Eleftheria Lamprianidou, Theodoros Vassilakopoulos, Sotirios G Papageorgiou, Athanasios G. Galanopoulos, Sofia Vakalopoulou, MD, PhD, Vassilia Garypidou, Emmanouil Spanoudakis, Maria Papaioannou, Evdoxia Hadjiharissi, Helen A Papadaki, Costas Tsatalas

Blood (2013) 122 (21): 1508.

https://doi.org/10.1182/blood.V122.21.1508.1508

Published: 2013

Journal Articles

Distinct Profile and Epigenetic Modulation Of STAT Signaling In FOXP3+ T Regulatory Cells Among The Various MDS Subtypes

Eleftheria Lamprianidou, Costas Tsatalas, Paraskevi Miltiades, Theodoros Vassilakopoulos, Athanasios G. Galanopoulos, Sotirios G Papageorgiou, Vassilia Garypidou, Sofia Vakalopoulou, MD, Emmanouil Spanoudakis, Dimitrios Margaritis, Ioannis Kotsianidis

Blood (2013) 122 (21): 1509.

https://doi.org/10.1182/blood.V122.21.1509.1509

Published: 2013

Journal Articles

A Study of the Expression of the LMP1 Oncoprotein in Low-Grade B Cell Lymphomas and Correlation with the Levels of Oxidative Stress

Panagiotis Theodorou Diamantopoulos, Vasiliki Papadopoulou, Aikaterini Polonyfi, Athanasios G. Galanopoulos, Fani Kalala, Konstantinos Zervakis, Theodoros Iliakis, Evangelos Terpos, Despoina Perrea, Nora-Athina Viniou

Blood (2012) 120 (21): 4833.

https://doi.org/10.1182/blood.V120.21.4833.4833

Published: 2012

Journal Articles

The Levels of a G-CSF-Inducible pSTAT3+pSTAT5+ Subpopulation of MDS Progenitors with Leukemic Stem Cell Phenotype Predict the Response to Azacytidine

Paraskevi Miltiades, Eleytheria Labrianidou, Theodoros P. Vassilakopoulos, Sotirios G Papageorgiou, Athanasios G. Galanopoulos, Sofia Vakalopoulou, MD, Ass.Prof.Hematology, Vassilia Garypidou, Evangelia Nakou, Emmanuil Spanoudakis, Maria Papaioannou, Helen A. Papadaki, MD, PhD, Vasiliki Pappa, Konstantinos Tsatalas, Ioannis Kotsianidis, MD, PhD

Blood (2012) 120 (21): 3795.

https://doi.org/10.1182/blood.V120.21.3795.3795

Published: 2012

Journal Articles

Deletion of Tumor Suppressor Genes (TSGS) in Patients with Myelodysplastic Syndrome (MDS).

Athanasios G. Galanopoulos, MD, PhD, Stephanos Papadhimitriou, MD, Ioannis Tsourveloudis, MD, Evridiki Michalis, MD, Theodoros Marinakis, MD, PhD, Anastasia Tsakiridou, MD, Ioanna Savvidou, MD, Vasilios Xanthopoulos, MD, George Theodoropoulos, MD, George Gortzolidis, MD, Athanasios Zomas, MD, Maria Georgiakaki, MD, Nikolaos I. Anagnostopoulos, MD, PhD

Blood (2005) 106 (11): 4907.

https://doi.org/10.1182/blood.V106.11.4907.4907

Published: 2005

Journal Articles

A Phase III Clinical Study of Treatment of Patients with Chronic Lymphoproliferative Disorders (CLPD) with Fludarabine, Cyclophosphamide, and Rituximab (FCR) Combination.

Athanasios G. Galanopoulos, MD, PhD, Anastasia Tsakiridou, MD, Eurydiki Michalis, MD, Theodoros Marinakis, MD, George Gortzolidis, MD, Athanasios Zomas, MD, Vasilios Xanthopoulos, MD, Ioanna Savvidou, MD, George Theodoropoulos, MD, Vasiliki Grigoraki, MD, Nikolaos I. Anagnostopoulos, MD, PhD

Blood (2005) 106 (11): 4740.

https://doi.org/10.1182/blood.V106.11.4740.4740

Published: 2005

Journal Articles

Treatment of Elderly Acute Myeloid Leukemia (AML) Patients with the Combination of Mitoxantrone and Cytarabine (MAC).

Theodoros Marinakis, MD, PhD, Athanasios G. Galanopoulos, MD, PhD, Athanasios Zomas, MD, Euridiki Michalis, MD, George Gortzolidis, MD, Anastasia Tsakiridou, MD, Vasilios Xanthopoulos, MD, George Theodoropoulos, MD, Helen Goumakou, MD, Maria Georgiakaki, MD, Vasiliki Grigoraki, MD, Nikolaos I. Anagnostopoulos, MD, PhD

Blood (2005) 106 (11): 4624.

https://doi.org/10.1182/blood.V106.11.4624.4624

Published: 2005

Journal Articles

Clinical Outcome of the Treatment of Adult Acute Lymphoblastic Leukemia (ALL) with the Hyper-CVAD Protocol.

Theodoros Marinakis, MD, PhD, Athanasios Zomas, MD, Athanasios G. Galanopoulos, MD, PhD, Eurydiki Michalis, MD, George Gortzolidis, MD, Ioannis Tsourveloudis, MD, Ioanna Savvidou, MD, George Theodoropoulos, MD, Stephanos Papadhimitriou, MD, George Paterakis, MD, Vasiliki Grigoraki, MD, Maria Georgiakaki, MD, Nikolaos I. Anagnostopoulos, MD, PhD

Blood (2005) 106 (11): 4588.

https://doi.org/10.1182/blood.V106.11.4588.4588

Published: 2005

Journal Articles

Treatment of Patients with Chronic Lymphoproliferative Disorders (CLPD) with Fludarabine, Cyclophosphamide, and Rituximab (FCR) Combination.

Athanasios G. Galanopoulos, MD, PhD, Anastasia Tsakiridou, MD, Eurydiki Michalis, MD, Theodoros Marinakis, MD, George Gortzolidis, MD, Athanasios Zomas, MD, Ioannis Tsourveloudis, MD, Maria Tsirogianni, MD, Stephanos Papadhimitriou, MD, Elpiniki Kritikou-Griva, MD, Nikolaos I. Anagnostopoulos, MD

Blood (2004) 104 (11): 4825.

https://doi.org/10.1182/blood.V104.11.4825.4825

Published: 2004

NARROW

Prognosis of Lower Risk Patients with Myelodysplastic Syndromes without Isolated Del(5q) after Failure of Erythropoiesis-Stimulating Agents. a Multicenter Study By the Hellenic MDS Study Group

CD4+ T Cells in High-Risk MDS Patients Bear an Aberrant STAT Signaling Biosignature

Decrease in Transfusion Needs in Patients with Higher-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia Treated with 5-Azacytidine. a Retrospective Study

Expression Of CD25 Antigen On CD34+ Cells Is An Independent Predictor Of Survival In Late Stage MDS Patients Treated With Azacitidine

Distinct Profile and Epigenetic Modulation Of STAT Signaling In FOXP3+ T Regulatory Cells Among The Various MDS Subtypes

A Study of the Expression of the LMP1 Oncoprotein in Low-Grade B Cell Lymphomas and Correlation with the Levels of Oxidative Stress

The Levels of a G-CSF-Inducible pSTAT3+pSTAT5+ Subpopulation of MDS Progenitors with Leukemic Stem Cell Phenotype Predict the Response to Azacytidine

Deletion of Tumor Suppressor Genes (TSGS) in Patients with Myelodysplastic Syndrome (MDS).

A Phase III Clinical Study of Treatment of Patients with Chronic Lymphoproliferative Disorders (CLPD) with Fludarabine, Cyclophosphamide, and Rituximab (FCR) Combination.

Treatment of Elderly Acute Myeloid Leukemia (AML) Patients with the Combination of Mitoxantrone and Cytarabine (MAC).

Clinical Outcome of the Treatment of Adult Acute Lymphoblastic Leukemia (ALL) with the Hyper-CVAD Protocol.

Treatment of Patients with Chronic Lymphoproliferative Disorders (CLPD) with Fludarabine, Cyclophosphamide, and Rituximab (FCR) Combination.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only